na.ramos
Submits third-party assay reports on material purchased directly. Based in Mysuru.
Section 1
Contribution
Purchases material, pays for assays, and submits the resulting reports to the index.
Records submitted
6
n=6
Annotations
0
n=0
Median purity submitted
99.41%
n=6
Suppliers covered
4
n=6
Section 2
Records submitted
A submitter chose to buy this material and to pay for this assay. That choice is the selection mechanism behind the whole index and it is not random.
| Report | Compound | Supplier | Lot | Lab | Quarter | Purity % | Water % | Recovery % | Provenance | Flags | Result |
|---|---|---|---|---|---|---|---|---|---|---|---|
| AX-2026-041480 | PT-141 (Bremelanotide) | QYB | QYB-2607-L5615 | Medutest | 2026-Q3 | 99.93 | 4.32 | 100.5 | Supplier-supplied | 0 | PASS |
| AX-2026-042637 | IGF-1 LR3 | GGPeps | GGPE-2604-K8140 | Janoshik | 2026-Q2 | 98.47 | 2.20 | — | Supplier-supplied | 0 | PASS |
| AX-2025-020098 | ARA-290 | GGPeps | GGPE-2511-F8277 | Janoshik | 2025-Q4 | 99.41 | 1.99 | 98.3 | Supplier-supplied | 1 | MARGINAL |
| AX-2025-018639 | Tirzepatide | QYB | QYB-2507-T5368 | PeptideMeter | 2025-Q4 | 99.91 | 6.21 | 90.3 | Supplier-supplied | 1 | MARGINAL |
| AX-2025-019551 | KPV | Homopeptide | HOMO-2411-P1141 | VendorInvestigate | 2025-Q1 | 98.70 | 5.08 | 97.8 | Buyer-sourced | 1 | FAIL |
| AX-2024-005139 | CJC-1295 (no DAC) | KP | KP-2411-Y4921 | Medutest | 2024-Q4 | 99.41 | 3.92 | 104.1 | Supplier-supplied | 2 | FAIL |
| Supplier | Records | Median purity |
|---|---|---|
| QYB | 2 | n<3 |
| GGPeps | 2 | n<3 |
| Homopeptide | 1 | n<3 |
| KP | 1 | n<3 |